Dexcom Inc Stock Market Value
| DXCM Stock | USD 134.00 2.48 1.89% |
| Symbol | DexCom |
DexCom Inc Price To Book Ratio
Is DexCom's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DexCom. If investors know DexCom will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DexCom listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.81 | Earnings Share 1.3 | Revenue Per Share 9.384 | Quarterly Revenue Growth 0.269 | Return On Assets 0.0641 |
The market value of DexCom Inc is measured differently than its book value, which is the value of DexCom that is recorded on the company's balance sheet. Investors also form their own opinion of DexCom's value that differs from its market value or its book value, called intrinsic value, which is DexCom's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DexCom's market value can be influenced by many factors that don't directly affect DexCom's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DexCom's value and its price as these two are different measures arrived at by different means. Investors typically determine if DexCom is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DexCom's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
DexCom 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to DexCom's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of DexCom.
| 05/30/2023 |
| 04/24/2024 |
If you would invest 0.00 in DexCom on May 30, 2023 and sell it all today you would earn a total of 0.00 from holding DexCom Inc or generate 0.0% return on investment in DexCom over 330 days. DexCom is related to or competes with Bone Biologics, Tivic Health, Thermogenesis Holdings, Nexalin Technology, and INVO Bioscience. DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose ... More
DexCom Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure DexCom's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess DexCom Inc upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.8 | |||
| Information Ratio | 0.0032 | |||
| Maximum Drawdown | 13.54 | |||
| Value At Risk | (2.78) | |||
| Potential Upside | 4.19 |
DexCom Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for DexCom's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as DexCom's standard deviation. In reality, there are many statistical measures that can use DexCom historical prices to predict the future DexCom's volatility.| Risk Adjusted Performance | 0.0355 | |||
| Jensen Alpha | (0) | |||
| Total Risk Alpha | (0.22) | |||
| Sortino Ratio | 0.004 | |||
| Treynor Ratio | 0.0839 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of DexCom's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
DexCom Inc Backtested Returns
We consider DexCom very steady. DexCom Inc secures Sharpe Ratio (or Efficiency) of 0.0509, which denotes the company had a 0.0509% return per unit of risk over the last 3 months. We have found thirty technical indicators for DexCom Inc, which you can use to evaluate the volatility of the firm. Please confirm DexCom's Downside Deviation of 1.8, mean deviation of 1.53, and Coefficient Of Variation of 2203.03 to check if the risk estimate we provide is consistent with the expected return of 0.12%. DexCom has a performance score of 3 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 1.1, which means a somewhat significant risk relative to the market. DexCom returns are very sensitive to returns on the market. As the market goes up or down, DexCom is expected to follow. DexCom Inc right now shows a risk of 2.29%. Please confirm DexCom Inc skewness, and the relationship between the potential upside and rate of daily change , to decide if DexCom Inc will be following its price patterns.
Auto-correlation | -0.62 |
Very good reverse predictability
DexCom Inc has very good reverse predictability. Overlapping area represents the amount of predictability between DexCom time series from 30th of May 2023 to 11th of November 2023 and 11th of November 2023 to 24th of April 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of DexCom Inc price movement. The serial correlation of -0.62 indicates that roughly 62.0% of current DexCom price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.62 | |
| Spearman Rank Test | -0.6 | |
| Residual Average | 0.0 | |
| Price Variance | 87.29 |
DexCom Inc lagged returns against current returns
Autocorrelation, which is DexCom stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting DexCom's stock expected returns. We can calculate the autocorrelation of DexCom returns to help us make a trade decision. For example, suppose you find that DexCom has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
DexCom regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If DexCom stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if DexCom stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in DexCom stock over time.
Current vs Lagged Prices |
| Timeline |
DexCom Lagged Returns
When evaluating DexCom's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of DexCom stock have on its future price. DexCom autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, DexCom autocorrelation shows the relationship between DexCom stock current value and its past values and can show if there is a momentum factor associated with investing in DexCom Inc.
Regressed Prices |
| Timeline |
Pair Trading with DexCom
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if DexCom position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DexCom will appreciate offsetting losses from the drop in the long position's value.Moving together with DexCom Stock
| 0.67 | NXL | Nexalin Technology | PairCorr |
Moving against DexCom Stock
| 0.77 | BBLG | Bone Biologics Corp Financial Report 20th of May 2024 | PairCorr |
| 0.74 | NUWE | Nuwellis Financial Report 14th of May 2024 | PairCorr |
| 0.73 | UNH | UnitedHealth Group Financial Report 12th of July 2024 | PairCorr |
| 0.73 | NAOV | NanoVibronix | PairCorr |
| 0.66 | HSTM | HealthStream Upward Rally | PairCorr |
The ability to find closely correlated positions to DexCom could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace DexCom when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back DexCom - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling DexCom Inc to buy it.
The correlation of DexCom is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as DexCom moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if DexCom Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for DexCom can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out DexCom Correlation, DexCom Volatility and DexCom Alpha and Beta module to complement your research on DexCom. Note that the DexCom Inc information on this page should be used as a complementary analysis to other DexCom's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for DexCom Stock analysis
When running DexCom's price analysis, check to measure DexCom's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DexCom is operating at the current time. Most of DexCom's value examination focuses on studying past and present price action to predict the probability of DexCom's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DexCom's price. Additionally, you may evaluate how the addition of DexCom to your portfolios can decrease your overall portfolio volatility.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |
DexCom technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.